Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Rocket Doctor AI raises private placement to $4.5 million due to strong demand
Rocket Doctor AI has increased its unbrokered private placement to gross proceeds of up to $4.5 million and continues to offer shares at $0.70 each. The stock trades at $0.56 (+3.7%) and has gained 105% over the past six months. The company filed an amended offering document on SEDAR+ and on its website. Rocket Doctor AI develops AI-powered healthcare solutions, including the Global Library of Medicine, and says it has already supported over 300 doctors in more than 700,000 patient consultations. » More on de.investing.com
Rocket Doctor AI reports quarterly loss and sharp revenue increase
For the quarter ended Sept. 30, 2025, Rocket Doctor AI posted a loss of CAD 0.05 per share versus CAD 0.030 loss in the year-ago quarter. Revenue rose 5,200 percent to CAD 0.5 million. The company presented the figures at a financial conference on Dec. 1, 2025. » More on finanzen.net
Financials
| (EUR) | Mar 2026 | |
|---|---|---|
| Revenue | 459.2K | - |
| Gross profit | -771.51K | - |
| Net profit | -2.89M | 109.81% |
| EBITDA | -2.38M | 72.88% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €36.72M |
Number of shares | 96.89M |
52-week high/low | €0.61 - €0.30 |
| Dividends | No |
Beta | -0.36 |
P/E ratio | -2.54 |
PEG ratio | 0.14 |
P/B ratio | 8.56 |
P/S ratio | 23.87 |
Company profile
| Name | Rocket Doctor AI Inc. |
| CEO | Essam Hamza |
| Employees | 3 |
Discover assets
Shareholders of Rocket Doctor AI Inc. also invest in the following assets
